StoneX Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,746
Closed -$253K 932
2025
Q4
$253K Buy
8,746
+530
+6% +$15.9K 0.01% 772
2025
Q3
$228K Sell
8,216
-847
-9% -$21.4K 0.01% 785
2025
Q2
$221K Buy
+9,063
New +$199K 0.01% 748
2024
Q4
Sell
-8,045
Closed -$206K 865
2024
Q3
$206K Sell
8,045
-888
-10% -$22.6K 0.09% 311
2024
Q2
$210K Buy
8,933
+652
+8% +$16.5K 0.1% 294
2024
Q1
$238K Buy
8,281
+238
+3% +$7.16K 0.12% 241
2023
Q4
$264K Sell
8,043
-73
-0.9% -$1.99K 0.14% 216
2023
Q3
$226K Buy
8,116
+54
+0.7% +$1.76K 0.13% 254
2023
Q2
$275K Buy
8,062
+982
+14% +$30.9K 0.15% 201
2023
Q1
$213K Buy
+7,080
New +$219K 0.13% 275
2022
Q4
Sell
-12,054
Closed -$396K 592
2022
Q3
$396K Sell
12,054
-703
-6% -$25.8K 0.07% 182
2022
Q2
$402K Buy
12,757
+1,641
+15% +$57.4K 0.07% 201
2022
Q1
$511K Buy
11,116
+1,303
+13% +$62.1K 0.05% 309
2021
Q4
$601K Buy
9,813
+1,005
+11% +$69.5K 0.07% 260
2021
Q3
$658K Buy
8,808
+259
+3% +$21.7K 0.09% 211
2021
Q2
$791K Buy
8,549
+1,142
+15% +$97.1K 0.12% 184
2021
Q1
$657K Sell
7,407
-4,018
-35% -$399K 0.12% 175
2020
Q4
$1.06M Buy
11,425
+2,722
+31% +$217K 0.23% 85
2020
Q3
$554K Buy
8,703
+3,786
+77% +$222K 0.18% 135
2020
Q2
$256K Buy
+4,917
New +$211K 0.1% 232

Other funds holding ARKG

StoneX Group's ARKG Position: Q1 2026 in Review

StoneX Group sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2026, closing a stake of 8,746 shares — an estimated $253K sold.

StoneX Group first reported a position in ARKG in Q2 2020 and held it in 20 quarters. The position peaked at $1.06M in Q4 2020. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • StoneX Group reported no remaining ARK Genomic Revolution ETF position as of Q1 2026 after selling out during the quarter.
  • StoneX Group sold 8,746 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $253K.
  • StoneX Group first reported a position in ARK Genomic Revolution ETF in Q2 2020 and held it in 20 quarters.
  • StoneX Group's ARK Genomic Revolution ETF position peaked at $1.06M in Q4 2020.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on StoneX Group's 13F filing for Q1 2026, filed 14 May 2026.